Condition
EBV Infection After Allogenic HSCT clinical trials and research
As of November 12, 2026, Find a Trial lists 2 EBV Infection After Allogenic HSCT clinical trials that are recruiting, in China. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Prevention of EBV Reactivation in Kids Undergoing Haploidentical Stem Cell Transplant with Rituximab Added to ATG Conditioning
This study tests whether giving two doses of rituximab during preconditioning can prevent EBV reactivation in children after a haploidentical stem cell transplant using ATG, and checks the safety of adding rituximab.
-
Using engineered T cells to treat EBV infection after stem cell transplant
This study is testing a new treatment using specially modified T cells to help patients who have developed Epstein-Barr virus infection after a stem cell transplant.
Related topics
Quick answers
How many EBV Infection After Allogenic HSCT clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.